摘要
Sigma Ventures is a venture capital (VC) firm that invests in technology, intelligent manufacturing, healthcare, and consumer services companies in their early and growth stage. In late 2017 Li Yuan, Sigma Ventures' founder and managing partner, needed to decide whether a startup called Isolimit was worth investing in. If so, then Isolimit was to be valued.
The case describes how Sigma Ventures assessed Isolimit's team, market, and technology and shows how Sigma used the venture capital method to evaluate its potential investment. Specifically, the case discusses three aspects of early-stage venture capital investments: (1) How should venture capital firms evaluate early-stage startups? (2) What is the logic of the venture capital method? (3) How should venture capital firms apply the venture capital method to determine the percentage stake they should receive in exchange for their investment?
源语言 | 英语 |
---|---|
页数 | 2 |
出版状态 | 已出版 - 25 8月 2023 |
案例编号
FIN-23-089案例规范编号
FIN-23-089-CE案例类型
Field Case更新日期
17/03/2024附注
For more details, please visit www.chinacases.org来源
China Europe International Business School案例学科表
- 金融与财务
案例行业表
- 金融与保险